Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of IMycobacterium tuberculosis/I

Due to the concerning rise in the number of multiple- and prolonged-drug-resistant (MDR and XDR) Mycobacterium tuberculosis (Mtb) strains, unprecedented demand has been created to design and develop novel therapeutic drugs with higher efficacy and safety. In this study, with a focused view on implem...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomolecules (Basel, Switzerland) Switzerland), 2022-09, Vol.12 (10)
Hauptverfasser:	Bajrai, Leena Hussein, Khateb, Aiah M, Alawi, Maha M, Felemban, Hashim R, Sindi, Anees A, Dwivedi, Vivek Dhar, Azhar, Esam Ibraheem
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioflavonoids Care and treatment Control Cytochrome P-450 Drug discovery Flavones Flavonoids Health aspects Methods Molecular dynamics Mycobacterium tuberculosis Physiological aspects Testing Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!